Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Trope, CG' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 53 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Davidson, B; Lazarovici, P; Ezersky, A; Nesland, JM; Berner, A; Risberg, B; Trope, CG; Kristensen, GB; Goscinski, M; van de Putte, G; Reich, R
      Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients

      CLINICAL CANCER RESEARCH
    2. Makar, APH; Scheistroen, M; Van den Weyngaert, D; Trope, CG
      Surgical management of stage I and II vulvar cancer: The role of the sentinel node biopsy. Review of literature

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    3. Davidson, B; Reich, R; Berner, A; Givant-Horwitz, V; Goldberg, I; Risberg, B; Kristensen, GB; Trope, CG; Bryne, M; Kopolovic, J; Nesland, JM
      Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels

      EUROPEAN JOURNAL OF CANCER
    4. Baekelandt, M; Lehne, G; Trope, CG; Szanto, I; Pfeiffer, P; Gustavssson, B; Kristensen, GB
      Phase I/II trial of the multidrug-resistance modulator valspodar combined with cisplatin and doxorubicin in refractory ovarian cancer

      JOURNAL OF CLINICAL ONCOLOGY
    5. Davidson, B; Risberg, B; Goldberg, I; Nesland, JM; Berner, A; Trope, CG; Kristensen, GB; Bryne, M; Reich, R
      Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients isa marker of poor outcome

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    6. Vergote, I; Timmerman, D; Fyles, A; Trope, CG; De Brabanter, J
      Cyst rupture during surgery - Authors' reply

      LANCET
    7. Vergote, I; De Brabanter, J; Fyles, A; Bertelsen, K; Einhorn, N; Sevelda, P; Gore, ME; Kaern, J; Verrelst, H; Sjovall, K; Timmerman, D; Vandewalle, J; Van Gramberen, M; Trope, CG
      Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma

      LANCET
    8. Davidson, B; Risberg, B; Berner, A; Nesland, JM; Trope, CG; Kristensen, GB; Bryne, M; Goscinski, M; de Putte, GV; Florenes, VA
      Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications

      GYNECOLOGIC ONCOLOGY
    9. Davidson, B; Goldberg, I; Berner, A; Nesland, JM; Givant-Horwitz, V; Byrne, M; Risberg, B; Kristensen, GB; Trope, CG; Kopolovic, J; Reich, R
      Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions

      AJCP. American journal of clinical pathology
    10. Trope, CG; Kristensen, G; Makar, A
      Surgery for borderline tumor of the ovary

      SEMINARS IN SURGICAL ONCOLOGY
    11. Baekelandt, M; Holm, R; Nesland, JM; Trope, CG; Kristensen, GB
      Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer

      JOURNAL OF CLINICAL ONCOLOGY
    12. Makar, AP; Kisic, J; Trope, CG
      Controversies in surgical management of advanced ovarian cancer (Stage III-IV)

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    13. Trope, CG; Kisic, J; Vergote, I
      Prognostic factors in platinum-resistant ovarian carcinoma treated with ifosfamide-etoposide

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    14. Berner, HS; Davidson, B; Berner, A; Risberg, B; Kristensen, GB; Trope, CG; Van de Putte, G; Nesland, JM
      Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma - diagnostic and prognostic implications

      CLINICAL & EXPERIMENTAL METASTASIS
    15. Baekelandt, MM; Holm, R; Nesland, JM; Trope, CG; Kristensen, GB
      P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer

      ANTICANCER RESEARCH
    16. Sundfor, K; Lyng, H; Trope, CG; Rofstad, EK
      Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization

      RADIOTHERAPY AND ONCOLOGY
    17. Davidson, B; Berner, A; Nesland, JM; Risberg, B; Kristensen, GB; Trope, CG; Bryne, M
      Carbohydrate antigen expression in primary tumors, metastatic lesions, andserous effusions from patients diagnosed with epithelial ovarian carcinoma: Evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions

      HUMAN PATHOLOGY
    18. Davidson, B; Berner, A; Nesland, JM; Risberg, B; Berner, HS; Trope, CG; Kristensen, GB; Bryne, M; Florenes, VA
      E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions

      JOURNAL OF PATHOLOGY
    19. Kraggerud, SM; Szymanska, J; Abeler, VM; Kaern, J; Eknaes, M; Heim, S; Teixeira, MR; Trope, CG; Peltomaki, P; Lothe, RA
      DNA copy number changes in malignant ovarian germ cell tumors

      CANCER RESEARCH
    20. Baekelandt, M; Nesbakken, AJ; Kristensen, GB; Trope, CG; Abeler, VM
      Carcinoma of the fallopian tube - Clinicopathologic study of 151 patients treated at the Norwegian Radium Hospital

      CANCER
    21. Rofstad, EK; Sundfor, K; Lyng, H; Trope, CG
      Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia induced radiation resistance rather than hypoxia-induced metastasis

      BRITISH JOURNAL OF CANCER
    22. Baekelandt, M; Holm, R; Trope, CG; Nesland, JM; Kristensen, GB
      Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: An immunohistochemical study

      CLINICAL CANCER RESEARCH
    23. Baekelandt, M; Holm, R; Trope, CG; Nesland, JM; Kristensen, GB
      The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer

      ANNALS OF ONCOLOGY
    24. Baekelandt, M; Kristensen, GB; Nesland, JM; Trope, CG; Holm, R
      Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 inadvanced ovarian cancer

      JOURNAL OF CLINICAL ONCOLOGY
    25. Baekelandt, M; Kristensen, GB; Trope, CG; Nesland, JM; Holm, R
      Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer

      ANTICANCER RESEARCH
    26. HOFSTRA LS; KRISTENSEN GB; WILLEMSE PHB; VINDEVOGHEL A; MEDEN H; LAHOUSEN M; OBERLING F; SORBE B; CRUMP M; SKLENAR I; SLUITER WJ; KIESE B; TROPE CG; DEVRIES EGE
      RANDOMIZED TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-3 VERSUS PLACEBO INPREVENTION OF BONE-MARROW DEPRESSION DURING FIRST-LINE CHEMOTHERAPY FOR OVARIAN-CARCINOMA

      Journal of clinical oncology
    27. NORDAL RR; KRISTENSEN GB; STENWIG AE; TROPE CG; NESLAND JM
      IMMUNOHISTOCHEMICAL ANALYSIS OF P53 PROTEIN IN UTERINE SARCOMAS

      Gynecologic oncology (Print)
    28. BJORGE T; ENGELAND A; HANSEN S; TROPE CG
      PROGNOSIS OF PATIENTS WITH OVARIAN-CANCER AND BORDERLINE TUMORS DIAGNOSED IN NORWAY BETWEEN 1954 AND 1993

      International journal of cancer
    29. BJORGE T; ENGELAND A; SUNDFOR K; TROPE CG
      PROGNOSIS OF 2,800 PATIENTS WITH EPITHELIAL OVARIAN-CANCER DIAGNOSED DURING 1975-94 AND TREATED AT THE NORWEGIAN RADIUM HOSPITAL

      Acta obstetricia et gynecologica Scandinavica
    30. DORUM A; MOLLER P; KAMSTEEG EJ; SCHEFFER H; BURTON M; HEIMDAL KR; MAEHLE LO; HOVIG E; TROPE CG; VANDERHOUT AH; VANDERMEULEN MA; BUYS CHCM; MEERMAN GJT
      A BRCA1 FOUNDER MUTATION, IDENTIFIED WITH HAPLOTYPE ANALYSIS, ALLOWING GENOTYPE PHENOTYPE DETERMINATION AND PREDICTIVE TESTING/

      European journal of cancer
    31. NORDAL RR; KRISTENSEN GB; STENWIG AE; NESLAND JM; PETTERSEN EO; TROPE CG
      AN EVALUATION OF PROGNOSTIC FACTORS IN UTERINE CARCINOSARCOMA

      Gynecologic oncology
    32. BJORGE T; ENGELAND A; HANSEN S; TROPE CG
      TRENDS IN THE INCIDENCE OF OVARIAN-CANCER AND BORDERLINE TUMORS IN NORWAY, 1954-1993

      International journal of cancer
    33. KRISTENSEN GB; KARLSEN F; JENKINS A; KAERN J; ABELER VM; TROPE CG
      HUMAN PAPILLOMA-VIRUS HAS NO PROGNOSTIC-SIGNIFICANCE IN CERVICAL-CARCINOMA

      European journal of cancer
    34. DORUM A; KRISTENSEN GB; ABELER VM; TROPE CG; MOLLER P
      EARLY DETECTION OF FAMILIAL OVARIAN-CANCER

      European journal of cancer
    35. SUNDFOR K; TROPE CG; KJORSTAD KE
      RADICAL RADIOTHERAPY VERSUS BRACHYTHERAPY PLUS SURGERY IN CARCINOMA OF THE CERVIX 2A AND 2B - LONG-TERM RESULTS FROM A RANDOMIZED STUDY 1968-1980

      Acta oncologica
    36. NORDAL RR; KRISTENSEN GB; KAERN J; STENWIG AE; PETTERSEN EO; TROPE CG
      THE PROGNOSTIC-SIGNIFICANCE OF SURGERY, TUMOR SIZE, MALIGNANCY GRADE,MENOPAUSAL STATUS, AND DNA-PLOIDY IN ENDOMETRIAL STROMAL SARCOMA

      Gynecologic oncology
    37. KRISTENSEN GB; HOLM R; ABELER VM; TROPE CG
      EVALUATION OF THE PROGNOSTIC-SIGNIFICANCE OF NM23 NDP KINASE PROTEIN EXPRESSION IN CERVICAL-CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY/

      Gynecologic oncology
    38. ABELER VM; VERGOTE IB; KJORSTAD KE; TROPE CG
      CLEAR-CELL CARCINOMA OF THE ENDOMETRIUM - PROGNOSIS AND METASTATIC PATTERN

      Cancer
    39. KRISTENSEN GB; HOLM R; ABELER VM; TROPE CG
      EVALUATION OF THE PROGNOSTIC-SIGNIFICANCE OF CATHEPSIN-D, EPIDERMAL GROWTH-FACTOR RECEPTOR, AND C-ERBB-2 IN EARLY CERVICAL SQUAMOUS-CELL CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY

      Cancer
    40. SUNDFOR K; TROPE CG; HOGBERG T; ONSRUD M; KOERN J; SIMONSEN E; BERTELSEN K; WESTBERG R
      RADIOTHERAPY AND NEOADJUVANT CHEMOTHERAPY FOR CERVICAL-CARCINOMA - A RANDOMIZED MULTICENTER STUDY OF SEQUENTIAL CISPLATIN AND 5-FLUOROURACIL AND RADIOTHERAPY IN ADVANCED CERVICAL-CARCINOMA STAGE 3B AND 4A

      Cancer
    41. KRISTENSEN GB; HOLM R; ABELER VM; TROPE CG
      THE PROGNOSTIC-SIGNIFICANCE OF NM23, CATHEPSIN-D, EGFR AND C-ERBB-2 IN CERVICAL-CANCER

      European journal of cancer
    42. NORDAL RR; KRISTENSEN GB; KAERN J; STENWIG AE; PETTERSEN EO; TROPE CG
      THE PROGNOSTIC-SIGNIFICANCE OF STAGE, TUMOR SIZE, CELLULAR ATYPIA ANDDNA-PLOIDY IN UTERINE LEIOMYOSARCOMA

      Acta oncologica
    43. KRISTENSEN GB; KAERN J; ABELER VM; HAGMAR B; TROPE CG; PETTERSEN EO
      NO PROGNOSTIC IMPACT OF FLOW-CYTOMETRIC MEASURED DNA-PLOIDY AND S-PHASE FRACTION IN CANCER OF THE UTERINE CERVIX - A PROSPECTIVE-STUDY OF 465 PATIENTS

      Gynecologic oncology
    44. MAKAR AP; BAEKELANDT M; TROPE CG; KRISTENSEN GB
      THE PROGNOSTIC-SIGNIFICANCE OF RESIDUAL DISEASE, FIGO SUBSTAGE, TUMORHISTOLOGY, AND GRADE IN PATIENTS WITH FIGO STAGE-III OVARIAN-CANCER

      Gynecologic oncology
    45. MAKAR AP; HOLM R; KRISTENSEN GB; NESLAND JM; TROPE CG
      THE EXPRESSION OF C-ERBB-2 (HER-2 NEU) ONCOGENE IN INVASIVE OVARIAN MALIGNANCIES/

      International journal of gynecological cancer
    46. KAERN J; TROPE CG; KRISTENSEN GB; PETTERSEN EO
      FLOW CYTOMETRIC DNA-PLOIDY AND S-PHASE HETEROGENEITY IN ADVANCED OVARIAN-CARCINOMA

      Cancer
    47. KAERN J; TROPE CG; KRISTENSEN GB; TVEIT KM; PETTERSEN EO
      EVALUATION OF DEOXYRIBONUCLEIC-ACID PLOIDY AND S-PHASE FRACTION AS PROGNOSTIC PARAMETERS IN ADVANCED EPITHELIAL OVARIAN-CARCINOMA - A PROSPECTIVE-STUDY

      American journal of obstetrics and gynecology
    48. KAERN J; TROPE CG; KRISTENSEN GB; ABELER VM; PETTERSEN EO
      DNA-PLOIDY - THE MOST IMPORTANT PROGNOSTIC FACTOR IN PATIENTS WITH BORDERLINE TUMORS OF THE OVARY

      International journal of gynecological cancer
    49. MAKAR AP; KAERN J; KRISTENSEN GB; VERGOTE I; BORMER OP; TROPE CG
      EVALUATION OF SERUM CA-125 LEVEL AS A TUMOR-MARKER IN BORDERLINE TUMORS OF THE OVARY

      International journal of gynecological cancer
    50. MAKAR AP; KRISTENSEN GB; BORMER OP; TROPE CG
      IS SERUM CA-125 AT THE TIME OF RELAPSE A PROGNOSTIC INDICATOR FOR FURTHER SURVIVAL PROGNOSIS IN PATIENTS WITH OVARIAN-CANCER

      Gynecologic oncology
    51. MAKAR AP; KRISTENSEN GB; BORMER OP; TROPE CG
      SERUM CA-125 LEVEL ALLOWS EARLY IDENTIFICATION OF NONRESPONDERS DURING INDUCTION CHEMOTHERAPY

      Gynecologic oncology
    52. VERGOTE IB; KAERN J; ABELER VM; PETTERSEN EO; DEVOS LN; TROPE CG
      ANALYSIS OF PROGNOSTIC FACTORS IN STAGE-I EPITHELIAL OVARIAN-CARCINOMA - IMPORTANCE OF DEGREE OF DIFFERENTIATION AND DEOXYRIBONUCLEIC-ACID PLOIDY IN PREDICTING RELAPSE

      American journal of obstetrics and gynecology
    53. KAERN J; WETTELAND J; TROPE CG; FARRANTS GW; JUHNG SW; PETTERSEN EO; REITH A; DANIELSEN HE
      COMPARISON BETWEEN FLOW-CYTOMETRY AND IMAGE CYTOMETRY IN PLOIDY DISTRIBUTION ASSESSMENTS IN GYNECOLOGIC CANCER

      Cytometry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/02/20 alle ore 14:18:41